Related Experiment Video

Updated: Jun 23, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Overcoming drug resistance by enhancing apoptosis of tumor cells

Pepita Giménez-Bonafé1, Avelina Tortosa, Ricardo Pérez-Tomás

  • 1Departament de Ciències Fisiològiques II, Campus Ciènces de Salut de Bellvitge, IDIBELL, University of Barcelona, Barcelona, Spain.

Current Cancer Drug Targets
|May 16, 2009
PubMed

Insights

Cancer cells resist treatment by blocking apoptosis, a programmed cell death process. Understanding molecular changes and developing new therapies targeting apoptosis are crucial for effective cancer treatment, especially in tumor stem cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • Drug resistance is a significant hurdle in cancer therapy.
  • Resistance to apoptosis (programmed cell death) is a key mechanism tumors use to evade cytotoxic agents and radiation.
  • Dysregulation of apoptosis contributes to cancer development and impacts treatment efficacy.

Purpose of the Study:

  • To review molecular alterations leading to apoptotic dysregulation in cancer.
  • To explore therapeutic strategies aimed at overcoming apoptosis resistance in tumors.
  • To emphasize the development of novel cancer therapeutics targeting tumor stem cells.

Main Methods:

  • Review of molecular mechanisms of apoptosis.
  • Analysis of anti-apoptotic factors (e.g., Bcl-2, BCLX(L), Bfl1/A1).
  • Examination of pro-apoptotic effector inactivation (e.g., p53 pathway).
  • Investigation of survival signal reinforcement (e.g., Survivin, FLIP, NF-kappaB).

Main Results:

  • Activation of anti-apoptotic factors and survival signals contributes to tumor cell resistance.
  • Inactivation of pro-apoptotic factors like p53 impairs cancer cell death.
  • Inhibition of apoptosis renders tumor cells resistant to chemotherapy and radiotherapy.

Conclusions:

  • Targeting molecular pathways that regulate apoptosis is essential for overcoming cancer drug resistance.
  • Developing therapeutic interventions to lower the apoptosis threshold in tumor cells offers promising treatment strategies.
  • Prioritizing the development of novel cancer therapeutics for tumor stem cells is critical for long-term treatment success.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...